Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1996
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2217545A1 Reverse two-hybrid systems
10/17/1996CA2217025A1 New chemokine expressed in eosinophils
10/17/1996CA2216858A1 Phospholipase c homolog
10/17/1996CA2215987A1 Glucose-inducible recombinant viral vector
10/17/1996CA2215141A1 Transgenic tomato plants containing a fusarium resistance gene
10/17/1996CA2191969A1 Transgenic fish in the treatment of diabetes
10/16/1996EP0737752A2 Fermentation media and methods for controlling norleucine content in polypeptides
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737749A1 Plants with modified stamen cells
10/16/1996EP0737748A1 Efficient production of transgenic fertile homozygous plants from fresh microspores
10/16/1996EP0737747A2 Cytoplasmatic expression in E. coli of antibodies, antibody fragments and fusions thereof
10/16/1996EP0737746A2 Production of recombinant polypeptides by bovine species and transgenic methods
10/16/1996EP0737745A1 Novel sugar-chain synthetase and process for producing the same
10/16/1996EP0737742A2 Pentose fermentation by recombinant zymomonas
10/16/1996EP0737314A1 Novel uses for gal4-receptor constructs
10/16/1996EP0737252A1 Gene therapy vector for the treatment of low or defective red blood cell production
10/16/1996EP0737251A1 Antibodies to egf receptor and their antitumour effect
10/16/1996EP0737250A1 Humanized antibodies and uses thereof
10/16/1996EP0737249A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor
10/16/1996EP0737248A1 Gene expression control
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737246A1 BACTERIAL STRAINS OF GENUS $i(BACILLUS) CLOSELY PHENOTYPICALLY RELATED TO GENUS $i(LACTOBACILLUS), CULTURE METHOD AND USE
10/16/1996EP0737208A1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
10/16/1996EP0737207A1 Inhibitors of human plasmin derived from the kunitz domains
10/16/1996EP0737085A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
10/16/1996EP0737076A1 Method for antigen-specific immunoregulation by t-cell alpha chain
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0737071A1 Anti-sense oligodeoxynucleotide to fibrogenic cytokines and use thereof
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/16/1996EP0543945B1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/16/1996EP0432168B1 Genetically engineered coccidiosis vaccine
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133599A Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
10/16/1996CN1133598A Acylated insulin
10/16/1996CN1133595A Mutants of the Rb and P53 genes and uses thereof
10/16/1996CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors
10/16/1996CN1133564A The Cloning of duffy blood group antigen
10/16/1996CN1133344A Universal DNA fragment extention technology and reagent box thereof
10/16/1996CN1133342A Antikanamycin gene originated from microbe
10/16/1996CN1133341A Adjusting and controlling factor for expression of nitrile solution deenzyme and gene thereof
10/16/1996CN1033042C Production method for new chlorella
10/16/1996CN1033034C Method for preparation of crystalline interleukin-4
10/15/1996US5565552 Method of expanded porphyrin-oligonucleotide conjugate synthesis
10/15/1996US5565549 Retroviruse, aids
10/15/1996US5565362 DNA sequences to target proteins to the mammary gland for efficient secretion
10/15/1996US5565358 Enhancer and silencer sequences isolated from the GPIIB promoter
10/15/1996US5565352 Deubiquitinating enzyme: compositions and methods
10/15/1996US5565351 Reducing the muscle protein loss by reducing proteolysis
10/15/1996US5565350 Compounds and methods for site directed mutations in eukaryotic cells
10/15/1996US5565347 Transformation and foreign gene expression with plant species
10/15/1996US5565346 Transformation and regeneration system for legumes
10/15/1996US5565344 Process for production of D-α-amino acids
10/15/1996US5565340 Method for suppressing DNA fragment amplification during PCR
10/15/1996US5565336 Nucleic acid molecule which codes a human interleukin mutein with increased activity and having a phenylalanine residue at position 171 replaced by leucine and a leucine residue at position 175 replaced by methionine
10/15/1996US5565335 Adhesion variants
10/15/1996US5565334 Enhancer sequence for modulating expression in epithelial cells
10/15/1996US5565333 Defined by a guanine to adenine transition at position 2976
10/15/1996US5565332 Production of chimeric antibodies - a combinatorial approach
10/15/1996US5565331 Nucleic acids encoding neural axon outgrowth modulators
10/15/1996US5565322 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to donor energy transfer system
10/15/1996US5565321 Isolating nucleic acid, amplifying nucleic acid derived from cd40 ligand gene, determining nucleotide sequence, comparing to standard, determining if protein is expressed which binds cd40
10/15/1996US5565204 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
10/15/1996US5565186 Transgenic mouse having genome comprised of native mouse gene having some codons replaced with corresponding human codons, rendering mouse susceptible to infection with prions which cause disease in humans
10/15/1996CA1338642C Bacterial methionine n-terminal peptidase
10/14/1996CA2174025A1 Agents modulating the response of neuronal cells to inhibition by mammalian central nervous system myelin
10/10/1996WO1996031781A1 System for releasing and isolating nucleic acids
10/10/1996WO1996031780A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids
10/10/1996WO1996031625A1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/10/1996WO1996031624A1 Method for detecting mammary cancer cells
10/10/1996WO1996031623A1 Polynucleotides for detecting leishmanias and method of detection of leishmanial protozoa
10/10/1996WO1996031621A2 Method for determining the responsiveness of individuals to 5-ht2 receptor modulating agents
10/10/1996WO1996031618A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
10/10/1996WO1996031617A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996WO1996031613A1 Expression library immunization
10/10/1996WO1996031612A2 Process for selection of transgenic plant cells
10/10/1996WO1996031611A1 Novel promoters for expressing proteins of interest in yeast
10/10/1996WO1996031610A2 Exopolysaccharide degrading enzyme and use of the same
10/10/1996WO1996031609A2 TRANSGENIC PLANTS EXPRESSING ACETYL CoA CARBOXYLASE GENE
10/10/1996WO1996031608A1 Plant pathogen resistance genes and uses thereof
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031606A1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases
10/10/1996WO1996031605A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996WO1996031604A1 Antibodies for the detection of hla-g
10/10/1996WO1996031603A2 Methods and compositions for regulating fadd
10/10/1996WO1996031602A1 Retroviral vectors
10/10/1996WO1996031601A1 Polynucleotide immunogenic agents
10/10/1996WO1996031600A1 Method of modulating gene expression without depleting complement
10/10/1996WO1996031599A1 Ndf peptides
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031597A1 Ascorbate peroxidase and assays using same
10/10/1996WO1996031523A1 Covalently cross-linked oligonucleotides, method for preparing same, and synthon used therein
10/10/1996WO1996031522A1 Methods for measuring physical characteristics of nucleic acids by microscopic imaging
10/10/1996WO1996031521A1 Inhibiting degradation of a degron-bearing protein
10/10/1996WO1996031242A1 RECOMBINANT β-CELL AND USES THEREOF
10/10/1996WO1996031241A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996WO1996031235A1 Composition for inducing a mucosal immune response
10/10/1996WO1996031224A1 Immunosuppressant
10/10/1996WO1996031115A1 Nucleic acids encoding ascorbate free radical reductase and their uses
10/10/1996WO1996031113A1 Plants with altered mitochondrial function
1 ... 3676 3677 3678 3679 3680 3681 3682 3683 3684 3685 3686 3687 3688 3689 3690 3691 3692 3693 3694 3695 3696 ... 4023